TGF-β1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells

Brain Research

Volumn 958, Issue 1, 2002, Pages 152-160

  Gómez Santos, Cristina ^a   Ambrosio, Santiago ^a   Ventura, Francesc ^a   Ferrer, Isidre ^a   Reiriz, Julia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dopamine; Human neuroblastoma; Tyrosine hydroxylase

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CATECHOLAMINE; CHOLINE ACETYLTRANSFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE 3 MONOOXYGENASE; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; DNA BINDING PROTEIN; ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; REPRESSOR PROTEIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD1 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TISSUE PLASMINOGEN ACTIVATOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CATECHOLAMINERGIC SYSTEM; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADRENERGIC SYSTEM; BIOSYNTHESIS; CELL SIZE; CENTRAL NERVOUS SYSTEM; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NEUROBLASTOMA; PHYSIOLOGY; UPREGULATION;

BONE MORPHOGENETIC PROTEINS; CATECHOLAMINES; CELL DIFFERENTIATION; CELL SIZE; CENTRAL NERVOUS SYSTEM; CULTURE MEDIA, SERUM-FREE; DNA-BINDING PROTEINS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; NEUROBLASTOMA; NEURONS; PHENOTYPE; REPRESSOR PROTEINS; SMAD PROTEINS; SMAD1 PROTEIN; SMAD4 PROTEIN; SYMPATHETIC NERVOUS SYSTEM; TISSUE PLASMINOGEN ACTIVATOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRETINOIN; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 0037146556     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03680-6     Document Type: Article

References (46)

1. Candia A.F., Watabe T., Hawley S.H.B., Onichtchouk D., Zhang Y., Derynck R., Niehrs C., Cho W.Y. Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development. 124:1997;4467-4480.
2. Chalazonitis A., Kalberg J., Twardzik D.R., Morrison R.S., Kessler J.A. Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 152:1992;121-132.
3. Commissiong J.W., Takeshima T., Johnston J.M., Shimoda K. Effects of transforming growth factors on dopaminergic neurons in culture. Neurochem. Int. 30:1997;393-399.
4. Encinas M., Iglesias M., Llecha N., Comella J.X. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem. 73:1999;1409-1421.
5. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Ceña V., Gallego C., Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75:2000;991-1003.
6. Farkas L.M., Jászai J., Unsicker K., Krielstein K. Characterization of bone morphogenetic protein family members as neurotrophic factors for cultured sensory neurons. Neuroscience. 92:1999;227-235.
7. Goldstein M. Long-and short-term regulation of tyrosine hydroxylase. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;189-195 Raven Press, New York.
8. Gómez C., Reiriz J., Piqué M., Gil J., Ferrer I., Ambrosio S. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 63:2001;421-428.
9. Goodall A.R., Danks K., Walker J.H., Ball S.G., Vaughan P.F. Occurrence of two types of secretory vesicles in the human neuroblastoma SH-SY5Y. J. Neurochem. 68:1997;1542-1552.
10. Guo S., Brush J., Teraoka H., Goddard A., Wilson S.W., Mullins M.C., Rosenthal A. Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/phox2a. Neuron. 24:1999;555-566.
11. Hollnagel A., Oehlmann V., Heymer J., Ruther U., Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274:1999;19838-19845.
12. Icard-Liepkalns C., Biguet N.F., Vyas S., Robert J.J., Sassone-Corsi P., Mallet J. AP-1 complex and c-fos transcription are involved in TPA provoked and trans-synaptic inductions of the tyrosine hydroxylase gene: insights into long-term regulatory mechanisms. J. Neurosci. Res. 32:1992;290-298.
13. Ikeda H., Pastuzko A., Ikegaki N., Kenneth R.H., Wilson D.F. 3,4-Dihydroxyphenylalanine (DOPA) metabolism and retinoic acid induced differentiation in human neuroblastoma. Neurochem. Res. 19:1994;1487-1494.
14. Iwasaki S., Hattori A., Sato M., Tsujimoto M., Kohno M. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. J. Biol. Chem. 271:1996;17360-17365.
15. Jordan J., Böttner M., Schluesener H.J., Unsicker K., Krieglstein K. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur. J. Neurosci. 9:1997;1699-1710.
16. Kaplan D.R., Matsumoto K., Lucarelli E., Thiele C.J. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron. 11:1993;321-331.
17. Kitamura Y., Kosaka T., Kakimura J.I., Matsuoka Y., Kohno Y., Nomura Y., Taniguchi T. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic cell death in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 54:1998;1046-1054.
18. Kobayashi M., Matsuaoka I., Kurihara K. Cholinergic differentiation of cultured sympathetic neurons induced by retinoic acid. Induction of choline acetyltransferase-mRNA and suppression of tyrosine hydroxylase-mRNA levels. FEBS Lett. 337:1994;259-264.
19. Krieglstein K., Unsicker K. Transforming growth factor-β promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity. Neuroscience. 63:1994;1189-1196.
20. Krieglstein K., Suter-Crazzolara C., Fischer W.H., Unsicker K. TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14:1995;736-742.
21. Krieglestein K., Maysinger D., Unsicker K. The survival of mesencephalic dopaminergic neurons to neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-β superfamily and characterization of the serum-free culture system. J. Neural Transm. [Suppl.]. 47:1996;247-258.
22. Lai C.T., Yu P.H. Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Biochem. Pharmacol. 53:1997;363-372.
23. Li W., Cogswell C.A., LoTurco J.J. Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. J. Neurosci. 18:1998;8853-8862.
24. Lim D.A., Tramontin A.D., Trevejo J.M., Herrera A.D., García-Verdugo J.M., Avarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron. 28:2000;713-726.
25. López-Rovira T., Chalaux E., Rosa J.L., Bartrons R., Ventura F. Interaction and functional cooperation of NF-kB with smads. J. Biol. Chem. 275:2000;28937-28946.
26. López-Rovira T., Chalaux E., Massagué J., Rosa J.L., Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277:2002;3176-3185.
27. Macleod M.R., Allsopp T.E., McLuckie J., Kelly J.S. Serum withdrawal causes apoptosis in SH-SY5Y cells. Brain Res. 889:2001;308-315.
28. Martinou J.C., Thai A.L.V., Valette A., Weber M.J. Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons in culture. Dev. Brain Res. 52:1990;175-181.
29. Maruyama W., Naoi M., Kasamatsu T., Hashizume Y., Takahashi T., Kohda K., Dostert P. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neurochem. 69:1997;322-329.
30. Massagué J. TGF-β signal transduction. Ann. Rev. Biochem. 67:1998;753-791.
31. Massagué J., Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:2000;1745-1754.
32. Mehler M.F., Mabie P.C., Zhang D., Kessler J.A. Bone morphogenetic proteins in the nervous system. Trends Neurosci. 20:1997;309-317.
33. Mena M.A., García de Yébenes J., Dwark A., Fahn S., Latov N., Herbert J., Flaster E., Slonim D. Biochemical properties of monoamine-rich human neuroblastoma cells. Brain Res. 486:1989;286-296.
34. Mena M.A., Casarejos M.J., Estrada C., de Yébenes J.G. Effects of retinoic acid on NB 69 human neuroblastoma cells and fetal rat mid brain neurons. J. Neural Transm. [P-D Sect.]. 8:1994;85-97.
35. Påhlman S., Ruusala A.I., Abrahamsson L., Mattsson M.E.K., Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol ester-induced differentiation. Cell Different. 14:1984;135-144.
36. Pennypacker K.R., Kuhn D.M., Billingsley M.L. Changes in expression of tyrosine hydroxylase immunoreactivity in human SMS-KCNR neuroblastoma following retinoic acid or phorbol ester-induced differentiation. Mol. Brain Res. 5:1989;251-258.
37. Poulsen K.T., Armanini M.P., Klein R.D., Hynes M.A., Philips H.S., Rosenthal A. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron. 13:1994;1245-1252.
38. Ray R.P., Wharton K.A. Twisted perspective: new insights into extracellular modulation of BMP signaling during development. Cell. 104:2001;801-804.
39. Reiriz J., Espejo M., Ventura F., Ambrosio S., Alberch J. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J. Neurobiol. 38:1999;161-170.
40. Schneider C., Wicht H., Enderich J., Wegner M., Rohrer H. Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron. 24:1999;861-870.
41. Seitz G., Gebhardt S., Beck J.F., Böhm W., Lode H.N., Niethammer D., Bruchelt G. Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci. Lett. 244:1998;33-36.
42. Semkova I., Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res. Rev. 30:1999;176-188.
43. Shah N.M., Groves A.K., Anderson D.J. Alternative neural crest cell fates are instructively promoted by TGFβ superfamily members. Cell. 85:1996;331-343.
44. Shi X., Yang X., Chen D., Chang Z., Cao X. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J. Biol. Chem. 274:1999;13711-13717.
45. Vyas S., Biguet N.F., Mallet J. Transcriptional and post-transcriptional regulation of tyrosine hydroxylase gene by protein kinase C. EMBO J. 9:1990;3707-3712.
46. Wilson S.I., Edlund T. Neural induction: towards a unifying mechanism. Nature Neurosci. Suppl. 4:2001;1161-1167.